Showing results (31-40 of 542) with videos related to
Sort By:
Pageof 55
Neurodegenerative Disease Management|June 6, 2018
Repository corticotropin injection in multiple sclerosis: an updateChristen F Kutz, Amy L DixNeurodegenerative Disease Management|September 3, 2025
A quantitative investigation of the handwriting kinematics in response to STN-DBS in Parkinson's disease patientsHalil Onder, Zehra Yavuz, Beyza Nur Cetin, et al.Neurodegenerative Disease Management|June 9, 2017
Clinical and radiological control of highly active relapsing-remitting multiple sclerosis with first-line natalizumabJosé Eustasio Meca-Lallana, Ester Carreón-Guarnizo, Rocío Hernández-Clares, et al.Neurodegenerative Disease Management|April 27, 2017
The impact of β-amyloid positron emission tomography on the diagnostic and treatment decisions of dementia expertsMichael L Ganz, Alie F Tawah, Shien Guo, et al.Neurodegenerative Disease Management|September 8, 2016
Freezing of gait in Parkinson's disease: from pathophysiology to emerging therapiesAlberto Cucca, Milton C Biagioni, Jori E Fleisher, et al.Neurodegenerative Disease Management|May 26, 2017
Identifying therapeutic targets for Alzheimer's disease with big dataNilüfer Ertekin-TanerNeurodegenerative Disease Management|June 1, 2018
Effect of tetrahydrocannabinol:cannabidiol oromucosal spray on activities of daily living in multiple sclerosis patients with resistant spasticity: a retrospective, observational studyJavier Mallada FrechínNeurodegenerative Disease Management|April 19, 2019
'Likelihood to be diagnosed or misdiagnosed': application to meta-analytic data for cognitive screening instrumentsJohn C Williamson, Andrew J LarnerNeurodegenerative Disease Management|August 5, 2020
Mitochondrial biology and the identification of biomarkers of Huntington's diseaseAndreas Neueder, Michael OrthNeurodegenerative Disease Management|February 26, 2015
Are the effects of APOE ϵ4 on cognitive function in nonclinical populations age- and gender-dependent?Jennifer Rusted, Roxana O CararePageof 55